| Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study JA Burger, MJ Keating, WG Wierda, E Hartmann, J Hoellenriegel, ... The Lancet Oncology 15 (10), 1090-1099, 2014 | 431 | 2014 |
| Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries L Pivodic, K Pardon, L Morin, J Addington-Hall, G Miccinesi, ... J Epidemiol Community Health 70 (1), 17-24, 2016 | 230 | 2016 |
| International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data J Cohen, L Pivodic, G Miccinesi, BD Onwuteaka-Philipsen, WA Naylor, ... British journal of cancer 113 (9), 1397-1404, 2015 | 226 | 2015 |
| Estimating the need for palliative care at the population level: a cross-national study in 12 countries L Morin, R Aubry, L Frova, R MacLeod, DM Wilson, M Loucka, A Csikos, ... Palliative medicine 31 (6), 526-536, 2017 | 196 | 2017 |
| Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities P Jain, H Kantarjian, A Nazha, S O’Brien, E Jabbour, CG Romo, S Pierce, ... Blood, The Journal of the American Society of Hematology 121 (24), 4867-4874, 2013 | 169 | 2013 |
| Accuracy of colposcopy in the diagnostic setting compared with the screening setting SB Cantor, M Cárdenas-Turanzas, DD Cox, EN Atkinson, ... Obstetrics & Gynecology 111 (1), 7-14, 2008 | 151 | 2008 |
| International variation in place of death of older people who died from dementia in 14 European and non-European countries T Reyniers, L Deliens, HR Pasman, L Morin, J Addington-Hall, L Frova, ... Journal of the American Medical Directors Association 16 (2), 165-171, 2015 | 140 | 2015 |
| Natural history of cervical intraepithelial neoplasia: a meta-analysis SB Cantor, N Atkinson, M Cardenas-Turanzas, JL Benedet, M Follen, ... Acta cytologica 49 (4), 405-415, 2005 | 90 | 2005 |
| Hematopoietic cell transplantation–specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the … UD Bayraktar, EJ Shpall, P Liu, SO Ciurea, G Rondon, M De Lima, ... Journal of clinical oncology 31 (33), 4207-4214, 2013 | 78 | 2013 |
| Place of death of children with complex chronic conditions: cross-national study of 11 countries C Håkanson, J Öhlén, U Kreicbergs, M Cardenas-Turanzas, DM Wilson, ... European journal of pediatrics 176, 327-335, 2017 | 73 | 2017 |
| A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia A Quintás-Cardama, N Daver, H Kim, C Dinardo, E Jabbour, T Kadia, ... Clinical Lymphoma Myeloma and Leukemia 14 (5), 401-410, 2014 | 69 | 2014 |
| See-and-treat strategy for diagnosis and management of cervical squamous intraepithelial lesions M Cárdenas-Turanzas, M Follen, JL Benedet, SB Cantor The lancet oncology 6 (1), 43-50, 2005 | 68 | 2005 |
| Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data J Cohen, K Beernaert, L Van den Block, L Morin, K Hunt, G Miccinesi, ... NPJ primary care respiratory medicine 27 (1), 14, 2017 | 65 | 2017 |
| Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high‐dose cytarabine‐based induction chemotherapy E Jabbour, N Daver, R Champlin, M Mathisen, B Oran, S Ciurea, I Khouri, ... American journal of hematology 89 (4), 395-398, 2014 | 63 | 2014 |
| The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we? M Cardenas-Turanzas, JA Freeberg, JL Benedet, EN Atkinson, DD Cox, ... Gynecologic oncology 107 (1), S138-S146, 2007 | 63 | 2007 |
| The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience P Jain, H Kantarjian, F Ravandi, D Thomas, S O'Brien, T Kadia, J Burger, ... Leukemia 28 (4), 973-975, 2014 | 62 | 2014 |
| Cross-validation of a sequential organ failure assessment score–based model to predict mortality in patients with cancer admitted to the intensive care unit M Cárdenas-Turanzas, J Ensor, C Wakefield, K Zhang, SK Wallace, ... Journal of critical care 27 (6), 673-680, 2012 | 61 | 2012 |
| Ibrutinib in combination with rituximab (iR) is well tolerated and induces a high rate of durable remissions in patients with high-risk chronic lymphocytic leukemia (CLL): new … JA Burger, MJ Keating, WG Wierda, J Hoellenriegel, G Jeyakumar, ... Blood, The Journal of the American Society of Hematology 122 (21), 675-675, 2013 | 57 | 2013 |
| Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experience O Benjamini, H Kantarjian, MB Rios, E Jabbour, S O’Brien, P Jain, ... Leukemia & lymphoma 55 (12), 2879-2886, 2014 | 55 | 2014 |
| Place of death of people living with Parkinson’s disease: a population-level study in 11 countries K Moens, D Houttekier, L Van den Block, R Harding, L Morin, S Marchetti, ... BMC palliative care 14, 1-9, 2015 | 53 | 2015 |
joachim cohenEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB)在 vub.ac.be 的电子邮件经过验证
